Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Disease
55%
Cancer Mortality
47%
Case-Control Study
35%
Colorectal Cancer
35%
Malignant Neoplasm
31%
Fructose
27%
Stomach Cancer
26%
Somatomedin C
22%
Prospective Study
20%
Cardiovascular Disease
19%
Circulating microRNA
18%
Carotenoid
17%
Somatomedin B
17%
Superoxide Dismutase
17%
HIV
17%
Somatomedin Binding Protein 3
17%
microRNA
16%
Lung Cancer
16%
Infection
15%
Breast Cancer
13%
Prevalence
13%
Ethanol
13%
Binding Protein
12%
Synapsin II
12%
Cancer Incidence
11%
High Fructose Corn Syrup
11%
Ischemic Heart Disease
10%
Diabetes Mellitus
10%
All Cause Mortality
10%
Disease Surveillance
10%
Retinol
10%
Epidemic
10%
Chronic Kidney Failure
10%
C Reactive Protein
9%
Colon Cancer
9%
microRNA 20a
8%
Biological Marker
7%
Non Insulin Dependent Diabetes Mellitus
7%
Tocopherol
7%
Nonalcoholic Fatty Liver
7%
Syndrome
6%
Adiponectin
6%
Mitochondrial DNA
6%
Chronic Obstructive Lung Disease
6%
Transforming Growth Factor
6%
Thioredoxin Interacting Protein
6%
microRNA 122
6%
Somatomedin
6%
Acquired Immune Deficiency Syndrome
6%
microRNA 126
6%
Carotene
6%
Cross-Sectional Study
6%
Graves Disease
5%
Provitamin
5%
Flu Like Syndrome
5%
Epidemiology
5%
Oxidized Low Density Lipoprotein
5%
Symptom
5%
Brain Derived Neurotrophic Factor
5%
Medicine and Dentistry
Cohort Analysis
69%
Cancer Mortality
31%
Hazard Ratio
30%
Colorectal Cancer
20%
Cancer Risk
20%
Breast Cancer
17%
Malignant Neoplasm
14%
Colon Cancer
12%
Body Mass Index
12%
Alcohol Consumption
11%
Cancer Incidence
10%
Apoplexy
10%
Chronic Kidney Disease
10%
Proportional Hazards Model
9%
Disease
8%
Stomach Cancer
8%
Diabetes Mellitus
7%
Medical History
7%
Flu Like Syndrome
6%
Pediatric Disease
6%
Somatomedin Binding Protein 3
6%
Somatomedin B
6%
Circulating microRNA
6%
Cardiovascular Disease
6%
Encephalitis
6%
Postmenopause
6%
Prospective Study
6%
Bile Duct Cancer
6%
Human Immunodeficiency Virus
5%
Lung Cancer
5%
Drinking Behavior
5%
Smoking
5%
Fructose
5%
Glomerular Filtration Rate
5%
Gallbladder Cancer
5%
Brain Disease
5%
Life Expectancy
5%
Infection
5%
Prevalence
5%
Keyphrases
Japan
61%
Confidence Interval
14%
Colorectal Cancer Risk
13%
DNA Methylation (DNAm)
13%
Hazard Ratio
13%
Insulin-like
11%
Cancer Mortality
10%
Incidence Rate
9%
Infectious Disease Surveillance
9%
Epidemic Warning
9%
Cardiovascular Disease
8%
Lung Cancer Risk
8%
Japanese Population
8%
Serum Levels
8%
JACC Study
8%
IGF-binding protein-3
7%
Growth Factors
7%
Binding Protein
7%
Japanese Workers
7%
Japanese Women
7%
Yakumo Study
7%
Peripheral Blood Mononuclear Cells
7%
Nationwide Epidemiological Survey
6%
Medical History
6%
Growth Factor Binding
6%
Mitochondrial DNA
6%
Second Term
6%
Health Expectancy
6%
Health Japan 21
6%
Aryl Hydrocarbon Receptor Repressor
6%
Nationwide Survey
6%
Colorectal Cancer Mortality
6%
Circulating microRNA
6%
Bowel Movement Frequency
6%
Television Viewing Time
6%
Encephalitis
6%
Mortality Risk
6%
Mortality Rate
6%
Odds Ratio
5%
Colorectal Cancer
5%
Insulin-like Growth Factor 2 (IGF2)
5%
Provitamin A
5%
Cancer Incidence
5%
Clinico-epidemiology
5%
Coronary Artery Disease
5%
Postmenopausal Women
5%
Type 1 Diabetes Mellitus (T1DM)
5%